{"title":"Evaluation of body composition during low-dose estrogen oral contraceptives treatment.","authors":"M Franchini, C Caruso, S Nigrelli, C Poggiali","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine in a prospective study if the use of two low-dose estrogen oral contraceptives is associated with changes in weight or body composition.</p><p><strong>Design: </strong>80 outpatients referring to the family planning service, aged 18-43 years were randomly assigned to a treatment with the EE/desogestrel or EE/gestodene association, 20 patients with IUD, aged 26-40 years, were selected as a control group. Anthropometric data and body composition were taken at enrollment and after 6 and 12 months.</p><p><strong>Main outcome measures: </strong>Anthropometric measurements included body mass index (BMI), body composition estimated by mean of Bioelectrical Impendance Analysis (BIA).</p><p><strong>Results: </strong>In the three groups weight, BMI, and total body water (TBW), and body cellular mass (BCM) remained unchanged during the study period.</p><p><strong>Conclusions: </strong>The use of EE/desogestrel and EE/gestodene is not associated with significant variations of body weight and body composition during one year treatment.</p>","PeriodicalId":7016,"journal":{"name":"Acta Europaea fertilitatis","volume":"26 2","pages":"69-73"},"PeriodicalIF":0.0000,"publicationDate":"1995-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Europaea fertilitatis","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To determine in a prospective study if the use of two low-dose estrogen oral contraceptives is associated with changes in weight or body composition.
Design: 80 outpatients referring to the family planning service, aged 18-43 years were randomly assigned to a treatment with the EE/desogestrel or EE/gestodene association, 20 patients with IUD, aged 26-40 years, were selected as a control group. Anthropometric data and body composition were taken at enrollment and after 6 and 12 months.
Main outcome measures: Anthropometric measurements included body mass index (BMI), body composition estimated by mean of Bioelectrical Impendance Analysis (BIA).
Results: In the three groups weight, BMI, and total body water (TBW), and body cellular mass (BCM) remained unchanged during the study period.
Conclusions: The use of EE/desogestrel and EE/gestodene is not associated with significant variations of body weight and body composition during one year treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
